| Catalog_no |
ADMC0155 |
| Product_name |
Duvelisib (IPI-145, INK1197) |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
1220.00/2660.00/4440.00 |
| Specificity |
Target: PI3K. Fields: IPI-145 is an orally bioavailable, highly selective and potent small molecule inhibitor of the delta and gamma isoforms of phosphoinositide-3 kinase (PI3K) with potential immunomodulating and antineoplastic activities. IC50: 1 |
| Dilution |
IC50: 1 nM (PI3K δ), 50 nM (PI3K γ) |
| Purification |
>98% |
| Concentration |
靶点：PI3K;IC50： 1 nM (PI3K δ), 50 nM (PI3K γ) |
| Storage_stability |
2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername |
IPI145; IPI 145; IPI-145. INK-1197; INK 1197; INK1197,Duvelisib (IPI-145, INK1197) |
| Molecular Weight |
416.86 |
| Notes |
IPI-145 is an orally bioavailable, highly selective and potent small molecule inhibitor of the delta and gamma isoforms of phosphoinositide-3 kinase (PI3K) with potential immunomodulating and antineoplastic activities. IC50: 1 nM (PI3K δ), 50 nM (PI3 |
| Instructions |
 查看与下载 |
